1
Kremer Bernd Karl Friedrich, Faendrich Fred, Ruhnke Maren: Dedifferentiated, programmable stem cells of monocytic origin, and their production and use. Blasticon Biotechnologische Fo, February 16, 2005: EP1506999-A1


The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmabl ...


2
Kremer Bernd Karl Friedrich, Faendrich Fred, Schulze Maren: Transplant acceptance inducing cells of monocytic origin and their preparation and use. Blasticon Biotechnologische Fo, July 27, 2005: EP1557462-A2


The invention relates to transplant acceptance inducing cells of monocytic origin, their production as well as their use for generating transplant acceptance. The invention also relates to the monoclonal antibody GM-7, which specifically recognises human transplant acceptance inducing cells of the i ...


3
Haverich Axel Prof Dr, Martin Ulrich Pd Dr, Faendrich Fred Pd Dr: Composition and method for inducing immune tolerance towards cell, tissue and/or organ transplants. Hannover Med Hochschule, May 18, 2005: EP1530970-A1


The present invention relates to a composition comprising embryonic stem cells or haematopoietic stem cells or precursor cells being obtained by differentiation of said embryonic stem cells as well as trophoblasts, throphoblasts precursor and/or placental cell derived from said trophopblasts, all ce ...


4
Bader Michael, Binas Bert, Chai Giuxuan, Faendrich Fred, Ganten Detlev, Lin Xiongbin: Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue. Max Delbrueck Centrum, September 10, 2003: EP1341915-A1


The invention relates to the use of cells from cell lines, which are derived from early embryonic stages, for the donor-specific increase in transplantation tolerance and for repairing damaged tissue. Areas of application of the invention include the field of medicine and the pharmaceutical industry ...


5
Kremer Bernd Karl Friedrich, Faendrich Fred, Ruhnke Maren: Dedifferentiated, programmable stem cells of monocytic origin, and their production and use. Blasticon Biotechnologische Fo, July 14, 2004: EP1436381-A1


The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmabl ...


6
Kremer Bernd Karl Friedrich, Faendrich Fred, Schulze Maren: Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations. Blasticon Biotechnologische Fo, April 12, 2006: EP1644484-A1


The invention relates to cells of monocytic origin suitable for the prevention and/or treatment of diseases associated with disturbed self-tolerance, in particular autoimmune diseases and allergies, and to pharmaceutical preparations containing these cells. The cells are autologous in relation to th ...


7
Kremer Bernd Karl Friedrich, Faendrich Fred, Ruhnke Maren: Dedifferentiated, programmable stem cells having a monocytic origin and the production and use thereof. Blasticon Biotechnologische Fo, December 29, 2004: EP1490479-A1


Producing dedifferentiated, programmable stem cells of human monocytic origin, comprises isolating monocytes from human blood, propagating the monocytes in a culture medium which contains the cellular growth factor M-CSF, cultivating the monocytes, subsequently or simultaneously, in a culture medium ...


8
Kremer Bernd Karl Friedrich, Faendrich Fred, Ruhnke Maren: Transplant acceptance inducing cells of monocytic origin and their preparation and use. Blasticon Biotechnologische Fo, January 5, 2005: EP1492869-A1


The invention relates to transplant acceptance inducing cells of monocytic origin, their production as well as their use for generating transplant acceptance. The invention also relates to the monoclonal antibody GM-7, which specifically recognises human transplant acceptance inducing cells of the i ...


9
Kremer Bernd Karl Friedrich, Faendrich Fred, Ruhnke Maren: Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations. Blasticon Biotechnologische Fo, guo wenji wang jingchao, August 23, 2006: CN200480019839


The invention relates to cells of monocytic origin suitable for the prevention and/or treatment of diseases associated with disturbed self-tolerance, in particular autoimmune diseases and allergies, and to pharmaceutical preparations containing these cells. The cells are autologous in relation to th ...


10
Kremer Bernd Karl Friedrich, Faendrich Fred, Ruhnke Maren: Dedifferentiated, programmable stem cells of monocytic origin, and their production and use. Blasticon Biotechnologische Fo, guo anxun wang jingchao, July 20, 2005: CN03807128


The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmabl ...



Click the thumbnails below to visualize the patent trend.